Navigation Links
WCC Smart Search & Match and Retica Announce Global Collaboration
Date:2/12/2008

Powerful Multi-Modal Fusion Platform Includes Innovative Biometric

Technology

RESTON, Virginia, February 12 /PRNewswire/ -- WCC Smart Search & Match, a leading provider of high-performance search and match software, today announced its collaboration with Retica Systems, a leader in providing innovative eye biometric technology for identification and authentication. Retica has developed both fast and accurate iris and retina matching algorithms and visionary hardware for capturing eye biometrics in the field and on the move. The collaboration will provide enhanced identification and authentication for WCC's ELISE ID - The Platform for Multi-Modal Fusion.

ELISE ID is capable of searching vast amounts of data - both biographic and complex biometric data - to deliver meaningful, ranked results extremely quickly. ELISE ID optimizes identity searching using advanced technologies to calculate similarities and rank results, allowing for true score-level fusion. ELISE ID's platform will incorporate Retica's eye biometrics to enhance its capabilities for multi-factor identification.

"Our collaboration with Retica provides an enhanced multi-modal search and match platform well suited to difficult environments where identification accuracy and speed are key for ensuring security," said Peter Went, CEO of WCC.

"Retica's image capture systems and identification algorithms capture and process an enormous amount of information. The ELISE ID platform handles that information with ease and provides end-users with an unparalleled level of control over an ever growing array of identification options." said Barry Morse, CEO at Retica. "We are excited to work with WCC Smart Search & Match to create a truly multi-modal platform for identification that can meet real world security challenges."

About WCC

WCC is a global technology leader in search and match software. Its ELISE matching system delivers the best possible identity matching results using multiple biometrics and/or biographic criteria. WCC's core competencies are in Identity Matching (biometrics), HR/staffing and other markets.

For more information, please visit: http://www.multimodalfusion.com

About Retica

Retica Systems is the leader in ocular biometric technology. Retica develops visionary image capture devices such as Mobile-Eyes, its see-through dual-iris hand-held collection device; and Eagle-Eyes, the world's first system for tracking and dual-iris identification of multiple moving subjects at distance. Retica also develops its own market leading iris, dual-iris, retina and fusion algorithms and related software products.

For more information, please visit: http://www.retica.com

Retica Systems and Retica are trademarks of Retica Systems, Inc.

ELISE is a registered trademark of WCC Group BV in the United States and other countries.


'/>"/>
SOURCE WCC Smart Search & Match
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Smart insulin nanostructures pass feasibility test, UT study reports
2. Netsmart Technologies Customer in Pennsylvania Recognized for Achieving Data Benchmarking Milestones
3. Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software
4. Smart Medical Technology, Inc. Awarded Novation Contract for Ground-breaking Liftaem(TM) System that Aids Lifting and Transferring Patients
5. Easily Lift, Transfer and Reposition Patients with Ground-Breaking Liftaem(TM) System from Smart Medical Technology, Inc.
6. Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions
7. Smart Genetics Announces Plans to Launch a New Alzheimers Risk Assessment Service
8. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
11. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... 3, 2016  With the growing need for ... is underway, therapies such as monoclonal antibodies, recombinant ... host of indications are in high demand. Conventionally ... development and production of these therapeutics. However, due ... high costs, novel approaches and novel expression systems ...
(Date:2/3/2016)... ... February 03, 2016 , ... Aerocom, a world-leading supplier of ... North American healthcare market. , Aerocom Healthcare, LLC will be based in Denver, ... provide new pneumatic tube systems or expand existing systems within the U.S. and ...
Breaking Biology Technology:
(Date:1/20/2016)... MINNETONKA, Minn. , Jan. 20, 2016   ... that supports the entire spectrum of clinical research, is ... in 2015. MedNet,s significant achievements are the result of ... of) iMedNet eClinical , it,s comprehensive, ... --> --> Key MedNet growth ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , ... a developer of innovative sensor-based diagnostic products, today announced the ... by new and existing investors.  Proceeds from the financing will ... Scanner , a hand-held device for detecting early-stage pressure ulcers. ... Ireland after receiving CE Mark approval. The ...
Breaking Biology News(10 mins):